Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Quan Q"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 31
Tytuł:
Cost-effectiveness analysis of Tislelizumab vs Sorafenib as the first-line treatment of unresectable hepatocellular carcinoma.
Autorzy:
Chen Q; College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Sun Q; Guangzhou ZhongWei Public Health Technology Accessment Institute, Guangzhou, China.
Zhang J; College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Li B; College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Feng Q; College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Liu J; College of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 04; Vol. 19 (3), pp. e0295090. Date of Electronic Publication: 2024 Mar 04 (Print Publication: 2024).
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Liver Neoplasms*/drug therapy
Antibodies, Monoclonal, Humanized*
Humans ; Sorafenib/therapeutic use ; Cost-Effectiveness Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A computational model of circRNA-associated diseases based on a graph neural network: prediction and case studies for follow-up experimental validation.
Autorzy:
Niu M; School of Electronic and Communication Engineering, Shenzhen Polytechnic University, Shenzhen, 518055, China.; School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China.
Wang C; Faculty of Computing, Harbin Institute of Technology, Harbin, 150000, Heilongjiang, China.
Zhang Z; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, China. .
Zou Q; Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, No. 4 Block 2 North Jianshe Road, Chengdu, 610054, China. .; Yangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou, China. .
Pokaż więcej
Źródło:
BMC biology [BMC Biol] 2024 Jan 29; Vol. 22 (1), pp. 24. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/genetics
Humans ; RNA, Circular/genetics ; RNA, Circular/analysis ; Follow-Up Studies ; Neural Networks, Computer ; Computer Simulation ; Computational Biology/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study.
Autorzy:
Ji X; Department of Radiation Oncology, Senior Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China.; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Xu Z; Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China.
Sun J; Department of Radiation Oncology, Senior Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
Li W; Department of Radiation Oncology, Senior Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
Duan X; Department of Radiation Oncology, Senior Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China. .; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China. .
Wang Q; Department of Radiation Oncology, Senior Department of Oncology, The Fifth Medical Center of PLA General Hospital, Beijing, China. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Jun 12; Vol. 18 (1), pp. 101. Date of Electronic Publication: 2023 Jun 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*
Radiosurgery*
Liver Neoplasms*
Thrombosis*
Humans ; Retrospective Studies ; Portal Vein
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Five-year survival post hepatectomy for colorectal liver metastases in a real-world Chinese cohort: Recurrence patterns and prediction for potential cure.
Autorzy:
Su YM; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
Liu W; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
Yan XL; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
Wang LJ; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
Liu M; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
Wang HW; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
Jin KM; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
Bao Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
Wang K; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
Li J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
Xu D; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
Xing BC; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatopancreatobiliary Surgery Department I, Peking University Cancer Hospital & Institute, Beijing, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (8), pp. 9559-9569. Date of Electronic Publication: 2023 Feb 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colorectal Neoplasms*/pathology
Liver Neoplasms*/secondary
Humans ; East Asian People ; Hepatectomy ; Neoplasm Recurrence, Local/surgery ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dose of intra-operative opioids has no impact on recurrence or survival in primary liver cancer.
Autorzy:
Zhao L; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
Teng L; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
Zhang W; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
Lin S; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
Liu X; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
Dai J; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
Shao H; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
Li X; Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Liu Q; Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
Zou H; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2022 Dec; Vol. 11 (24), pp. 4927-4934. Date of Electronic Publication: 2022 May 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Neoplasms*/drug therapy
Liver Neoplasms*/surgery
Liver Neoplasms*/etiology
Carcinoma, Hepatocellular*
Humans ; Analgesics, Opioid ; Retrospective Studies ; Cohort Studies ; Hepatectomy/adverse effects ; Fentanyl ; Neoplasm Recurrence, Local/surgery ; Disease-Free Survival
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Injectable magnetic montmorillonite colloidal gel for the postoperative treatment of hepatocellular carcinoma.
Autorzy:
Chen S; Anhui Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China.
Song Y; Anhui Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China.
Yan X; Anhui Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China.
Dong L; Division of Nanomaterials & Chemistry, Department of Modern Mechanics, Department of Radiology, Hefei National Laboratory for Physical Sciences at the Microscale, The First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China, Hefei, 230026, China. .; Chinese Academy of Sciences, Institute of Basic Medicine and Cancer (IBMC), The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, 310022, Zhejiang, China. .
Xu Y; Division of Nanomaterials & Chemistry, Department of Modern Mechanics, Department of Radiology, Hefei National Laboratory for Physical Sciences at the Microscale, The First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China, Hefei, 230026, China.
Xuan S; Division of Nanomaterials & Chemistry, Department of Modern Mechanics, Department of Radiology, Hefei National Laboratory for Physical Sciences at the Microscale, The First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China, Hefei, 230026, China.
Shu Q; Division of Nanomaterials & Chemistry, Department of Modern Mechanics, Department of Radiology, Hefei National Laboratory for Physical Sciences at the Microscale, The First Affiliated Hospital of University of Science and Technology of China, University of Science and Technology of China, Hefei, 230026, China.
Cao B; Department of General Surgery, Department of Ultrasonics, Department of Interventional Radiology, Anhui No. 2 Provincial People's Hospital, Hefei, 230041, Anhui, China.
Hu J; Department of General Surgery, Department of Ultrasonics, Department of Interventional Radiology, Anhui No. 2 Provincial People's Hospital, Hefei, 230041, Anhui, China.
Xing H; Anhui Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China.
Wu W; Anhui Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China.
Zha Z; Anhui Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China. .
Lu Y; Anhui Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2022 Aug 19; Vol. 20 (1), pp. 381. Date of Electronic Publication: 2022 Aug 19.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/pathology
Hyperthermia, Induced*
Liver Neoplasms*/drug therapy
Liver Neoplasms*/pathology
Animals ; Bentonite/therapeutic use ; Magnetic Phenomena ; Rabbits
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC).
Autorzy:
Wang W; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Ave., New York, NY, 10029, USA.; Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Sema4, Stamford, CT, USA.
Chen Y; The Hepatic Surgery Centre at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China.
Wu L; BGI, Shenzhen, China.
Zhang Y; Department of Mathematics, Hebei University of Science and Technology, Shijiazhuang, Hebei, China.
Yoo S; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Ave., New York, NY, 10029, USA.; Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Sema4, Stamford, CT, USA.
Chen Q; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Ave., New York, NY, 10029, USA.; Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Sema4, Stamford, CT, USA.
Liu S; BGI, Shenzhen, China.
Hou Y; BGI, Shenzhen, China.
Chen XP; The Hepatic Surgery Centre at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China.
Chen Q; The Division of Gastroenterology, Department of Internal Medicine at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China. .
Zhu J; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Ave., New York, NY, 10029, USA. .; Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. .; Sema4, Stamford, CT, USA. .; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. .
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2022 Jun 16; Vol. 15 (1), pp. 134. Date of Electronic Publication: 2022 Jun 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/genetics
Liver Neoplasms*/pathology
DNA Copy Number Variations ; DNA, Viral/genetics ; Hepatitis B virus/genetics ; Humans ; Virus Integration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis.
Autorzy:
Huang ZH; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China.
Lu GY; The First Affiliated Hospital of Xiamen University, Xiamen, 361003, Fujian, China.
Qiu LX; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China.
Zhong GH; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China.
Huang Y; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China.
Yao XM; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China.
Liu XH; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China.
Huang SJ; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China.
Wu T; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China.
Yuan Q; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China.
Wang YB; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China. .
Su YY; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China. .
Zhang J; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China.
Xia NS; State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Strait Collaborative Innovation Center of Biomedicine and Pharmaceutics, School of Public Health, Xiamen University, Fujian, 361102, Xiamen, China.; The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen, 361102, Fujian, China.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Mar 17; Vol. 22 (1), pp. 287. Date of Electronic Publication: 2022 Mar 17.
Typ publikacji:
Comparative Study; Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Carcinoma, Hepatocellular/*epidemiology
Guanine/*analogs & derivatives
Hepatitis B, Chronic/*drug therapy
Liver Neoplasms/*epidemiology
Tenofovir/*therapeutic use
Antiviral Agents/therapeutic use ; Carcinoma, Hepatocellular/prevention & control ; Carcinoma, Hepatocellular/virology ; Guanine/therapeutic use ; Hepatitis B, Chronic/complications ; Hepatitis B, Chronic/virology ; Humans ; Incidence ; Liver Cirrhosis/complications ; Liver Cirrhosis/virology ; Liver Neoplasms/prevention & control ; Liver Neoplasms/virology ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Machine learning algorithm and deep neural networks identified a novel subtype in hepatocellular carcinoma.
Autorzy:
Zi Q; Department of Engineering Structure and Mechanics, Wuhan University of Technology, Wuhan, Hubei, China.
Cui H; Department of Science and Education, Shenzhen Samii Medical Center, Shenzhen, Guangdong, China.
Liang W; Division of Nephrology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Chi Q; Department of Engineering Structure and Mechanics, Wuhan University of Technology, Wuhan, Hubei, China.
Pokaż więcej
Źródło:
Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2022; Vol. 35 (3), pp. 305-320.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/genetics
Liver Neoplasms*/genetics
Humans ; Neural Networks, Computer ; Machine Learning ; Algorithms
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Potent antitumor activity of a glutamyltransferase-derived peptide via an activation of oncosis pathway.
Autorzy:
Fang C; Department of Hepatic Surgery IV, Third Affiliated Hospital of Second Military Medical University, Shanghai, 200438, China.
Li W; Department of Gynecology and Obstetrics, First Affiliated Hospital of Second Military Medical University, Shanghai, 200438, China.
Yin R; Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Zhu D; Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Liu X; Anhui Key Laboratory for Cellular Dynamics and Chemical Biology, Hefei National Science Center, University of Science and Technology of China, Hefei, 230000, China.
Wu H; Anhui Key Laboratory for Cellular Dynamics and Chemical Biology, Hefei National Science Center, University of Science and Technology of China, Hefei, 230000, China.
Wang Q; Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Wang W; Anhui Key Laboratory for Cellular Dynamics and Chemical Biology, Hefei National Science Center, University of Science and Technology of China, Hefei, 230000, China.
Bai Q; Key Lab of Modern Separation Science in Shaanxi Province, Northwest University, Xi'an 710069, China.
Chen B; Department of Gynecology and Obstetrics, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Yao X; Anhui Key Laboratory for Cellular Dynamics and Chemical Biology, Hefei National Science Center, University of Science and Technology of China, Hefei, 230000, China. .
Chen Y; Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Aug 13; Vol. 11 (1), pp. 16507. Date of Electronic Publication: 2021 Aug 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Carcinoma, Hepatocellular/*drug therapy
Liver Neoplasms/*drug therapy
Peptides/*therapeutic use
Antineoplastic Agents/isolation & purification ; Cell Death/drug effects ; Cell Line, Tumor ; Fetal Blood/chemistry ; Humans ; Peptides/isolation & purification
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Characterization of genomic alterations in Chinese colorectal cancer patients with liver metastases.
Autorzy:
Wang HW; Hepatopancreatobiliary Surgery Department I, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Haidian District, Beijing, China.
Yan XL; Hepatopancreatobiliary Surgery Department I, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Haidian District, Beijing, China.
Wang LJ; Hepatopancreatobiliary Surgery Department I, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Haidian District, Beijing, China.
Zhang MH; GloriousMed Clinical Laboratory (Shanghai) Co., Ltd, Shanghai, China.
Yang CH; GloriousMed Clinical Laboratory (Shanghai) Co., Ltd, Shanghai, China.
Wei-Liu; Hepatopancreatobiliary Surgery Department I, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Haidian District, Beijing, China.
Jin KM; Hepatopancreatobiliary Surgery Department I, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Haidian District, Beijing, China.
Bao Q; Hepatopancreatobiliary Surgery Department I, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Haidian District, Beijing, China.
Li J; Hepatopancreatobiliary Surgery Department I, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Haidian District, Beijing, China.
Wang K; Hepatopancreatobiliary Surgery Department I, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Haidian District, Beijing, China.
Xing BC; Hepatopancreatobiliary Surgery Department I, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Haidian District, Beijing, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2021 Jul 19; Vol. 19 (1), pp. 313. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Colorectal Neoplasms*/genetics
Liver Neoplasms*/genetics
China ; DNA Copy Number Variations/genetics ; Filaggrin Proteins ; Genomics ; Humans ; Mutation/genetics ; Phosphatidylinositol 3-Kinases
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Liver resection for colorectal liver-limited metastases in elderly patients: a propensity score matching analysis.
Autorzy:
Jin KM; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatobiliary and Pancreatic Surgery Unit I, Peking University Cancer Hospital & Institute, No. 52, Fu Cheng Road, Beijing, 100142, People's Republic of China.
Wang K; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatobiliary and Pancreatic Surgery Unit I, Peking University Cancer Hospital & Institute, No. 52, Fu Cheng Road, Beijing, 100142, People's Republic of China.
Bao Q; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatobiliary and Pancreatic Surgery Unit I, Peking University Cancer Hospital & Institute, No. 52, Fu Cheng Road, Beijing, 100142, People's Republic of China.
Wang HW; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatobiliary and Pancreatic Surgery Unit I, Peking University Cancer Hospital & Institute, No. 52, Fu Cheng Road, Beijing, 100142, People's Republic of China.
Xing BC; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Hepatobiliary and Pancreatic Surgery Unit I, Peking University Cancer Hospital & Institute, No. 52, Fu Cheng Road, Beijing, 100142, People's Republic of China. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2020 Oct 24; Vol. 18 (1), pp. 275. Date of Electronic Publication: 2020 Oct 24.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/surgery
Liver Neoplasms*/surgery
Aged ; Disease-Free Survival ; Hepatectomy ; Humans ; Prognosis ; Propensity Score ; Proto-Oncogene Mas ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Circ-SPECC1 modulates TGFβ2 and autophagy under oxidative stress by sponging miR-33a to promote hepatocellular carcinoma tumorigenesis.
Autorzy:
Zhang B; Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China.; Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Liu Z; Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China.; Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Cao K; Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China.; Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Shan W; Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China.; Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Liu J; Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China.; Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Wen Q; Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China.; Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Wang R; Institute of Digestive Diseases, Xuzhou Medical University, Xuzhou, Jiangsu, China.; Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2020 Aug; Vol. 9 (16), pp. 5999-6008. Date of Electronic Publication: 2020 Jul 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
MeSH Terms:
Autophagy*/drug effects
Carcinoma, Hepatocellular/*etiology
Cell Cycle Proteins/*metabolism
Cytoskeletal Proteins/*metabolism
Liver Neoplasms/*etiology
MicroRNAs/*metabolism
Transforming Growth Factor beta2/*metabolism
Adenine/analogs & derivatives ; Adenine/pharmacology ; Animals ; Apoptosis/drug effects ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/prevention & control ; Cell Cycle Proteins/drug effects ; Cell Cycle Proteins/genetics ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cytoskeletal Proteins/drug effects ; Cytoskeletal Proteins/genetics ; Down-Regulation ; Humans ; Hydrogen Peroxide/pharmacology ; Liver Neoplasms/metabolism ; Liver Neoplasms/prevention & control ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; MicroRNAs/antagonists & inhibitors ; Oxidative Stress
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Biologically effective dose (BED) escalation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma patients (≤5 cm) with CyberKnife: protocol of study.
Autorzy:
Sun J; Radiation Oncology Center, The Fifth Medical Center of PLA General Hospital (Beijing 302 Hospital), No. 100 Xi Si Huan Middle Road, Fengtai District, Beijing, 100039, China.
Zhang A; Radiation Oncology Center, The Fifth Medical Center of PLA General Hospital (Beijing 302 Hospital), No. 100 Xi Si Huan Middle Road, Fengtai District, Beijing, 100039, China.
Li W; Radiation Oncology Center, The Fifth Medical Center of PLA General Hospital (Beijing 302 Hospital), No. 100 Xi Si Huan Middle Road, Fengtai District, Beijing, 100039, China.
Wang Q; Radiation Oncology Center, The Fifth Medical Center of PLA General Hospital (Beijing 302 Hospital), No. 100 Xi Si Huan Middle Road, Fengtai District, Beijing, 100039, China.
Li D; Radiation Oncology Center, The Fifth Medical Center of PLA General Hospital (Beijing 302 Hospital), No. 100 Xi Si Huan Middle Road, Fengtai District, Beijing, 100039, China.
Zhang D; Radiation Oncology Center, The Fifth Medical Center of PLA General Hospital (Beijing 302 Hospital), No. 100 Xi Si Huan Middle Road, Fengtai District, Beijing, 100039, China.
Duan X; Radiation Oncology Center, The Fifth Medical Center of PLA General Hospital (Beijing 302 Hospital), No. 100 Xi Si Huan Middle Road, Fengtai District, Beijing, 100039, China. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2020 Jan 28; Vol. 15 (1), pp. 20. Date of Electronic Publication: 2020 Jan 28.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*radiotherapy
Liver Neoplasms/*radiotherapy
Radiosurgery/*methods
Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/pathology ; Dose Fractionation, Radiation ; Humans ; Liver/radiation effects ; Liver Neoplasms/mortality ; Liver Neoplasms/pathology ; Radiation Injuries/etiology ; Radiosurgery/adverse effects ; Relative Biological Effectiveness ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Repeated CyberKnife stereotactic body radiation therapy in hepatocellular carcinoma.
Autorzy:
Sun J; Department of Radiation Oncology, The Fifth Medical Center of PLA General Hospital (302 Military Hospital), Beijing, 100039, China.
Ouyang C; Department of Radiation Oncology, The Fifth Medical Center of PLA General Hospital (302 Military Hospital), Beijing, 100039, China.
Chang X; Department of Radiation Oncology, The Fifth Medical Center of PLA General Hospital (302 Military Hospital), Beijing, 100039, China.
Zhang A; Department of Radiation Oncology, The Fifth Medical Center of PLA General Hospital (302 Military Hospital), Beijing, 100039, China.
Wang Q; Department of Radiation Oncology, The Fifth Medical Center of PLA General Hospital (302 Military Hospital), Beijing, 100039, China.
Li W; Department of Radiation Oncology, The Fifth Medical Center of PLA General Hospital (302 Military Hospital), Beijing, 100039, China.
Zhang D; Department of Radiation Oncology, The Fifth Medical Center of PLA General Hospital (302 Military Hospital), Beijing, 100039, China.
Wang J; Department of Radiation Oncology, The Fifth Medical Center of PLA General Hospital (302 Military Hospital), Beijing, 100039, China.
Li D; Department of Radiation Oncology, The Fifth Medical Center of PLA General Hospital (302 Military Hospital), Beijing, 100039, China.
Duan X; Department of Radiation Oncology, The Fifth Medical Center of PLA General Hospital (302 Military Hospital), Beijing, 100039, China. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2020 Jan 09; Vol. 15 (1), pp. 10. Date of Electronic Publication: 2020 Jan 09.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*radiotherapy
Liver Neoplasms/*radiotherapy
Radiosurgery/*methods
Adult ; Aged ; Carcinoma, Hepatocellular/mortality ; Female ; Humans ; Liver Neoplasms/mortality ; Male ; Middle Aged ; Radiosurgery/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Synthesis of Cucurbitacin B Derivatives as Potential Anti-Hepatocellular Carcinoma Agents.
Autorzy:
Ge W; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China. .
Chen X; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China. .
Han F; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China. .
Liu Z; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China. .
Wang T; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China. .
Wang M; Accendatech Company, Ltd., Tianjin 300384, China. .
Chen Y; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China. .
Ding Y; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China. .
Zhang Q; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China. .
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2018 Dec 18; Vol. 23 (12). Date of Electronic Publication: 2018 Dec 18.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*metabolism
Liver Neoplasms/*metabolism
Triterpenes/*pharmacology
Apoptosis/drug effects ; Cell Proliferation/drug effects ; Hep G2 Cells ; Humans ; STAT3 Transcription Factor/metabolism ; Triterpenes/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ex vivo liver resection and autotransplantation with cardiopulmonary bypass for hepatoblastoma in children: A case report.
Autorzy:
Shi SJ; Department of Hepatobiliary Surgery, Children's Hospital of Chongqing Medical University, Chongqing, China.
Wang DL; Department of Hepatobiliary Surgery, Children's Hospital of Chongqing Medical University, Chongqing, China.
Hu W; Department of Hepatobiliary Surgery, Children's Hospital of Chongqing Medical University, Chongqing, China.
Peng F; Department of Hepatobiliary Surgery, Children's Hospital of Chongqing Medical University, Chongqing, China.
Kang Q; Department of Hepatobiliary Surgery, Children's Hospital of Chongqing Medical University, Chongqing, China.; Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing Engineering Research Center of Stem Cell Therapy, China International Science and Technology Cooperation base of Child Development and Critical Disorders, Chongqing, China.
Pokaż więcej
Źródło:
Pediatric transplantation [Pediatr Transplant] 2018 Nov; Vol. 22 (7), pp. e13268. Date of Electronic Publication: 2018 Jul 12.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hepatectomy/*methods
Hepatoblastoma/*surgery
Liver Neoplasms/*surgery
Liver Transplantation/*methods
Female ; Humans ; In Vitro Techniques ; Infant ; Transplantation, Autologous
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of potential transcription factors, long noncoding RNAs, and microRNAs associated with hepatocellular carcinoma.
Autorzy:
Yan H; Department of Hepatobiliary Surgery, Henan Provincial People's Hospital, Zhengzhou, Henan 650000, P.R. China.
Wang Q; Department of Hepatobiliary Surgery, Henan Cancer Hospital, Zhengzhou, Henan 650000, P.R. China.
Shen Q; Department of Hepatobiliary Surgery, Henan Provincial People's Hospital, Zhengzhou, Henan 650000, P.R. China.
Li Z; Secondary Department of General Surgery, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, Henan 471003, P.R. China.
Tian J; Department of Hepatobiliary Surgery, Henan Provincial People's Hospital, Zhengzhou, Henan 650000, P.R. China.
Jiang Q; Department of Hepatobiliary Surgery, Henan Provincial People's Hospital, Zhengzhou, Henan 650000, P.R. China.
Gao L; Laboratory of Molecular and Translational Medicine, West China Institute of Women and Children's Health; Key Laboratory of Obstetric and Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2018 Sep; Vol. 14 (Supplement), pp. S622-S627.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*genetics
Hepatocyte Nuclear Factor 4/*genetics
Histone Acetyltransferases/*genetics
Liver Neoplasms/*genetics
MicroRNAs/*genetics
RNA, Long Noncoding/*genetics
TATA-Binding Protein Associated Factors/*genetics
Transcription Factor TFIID/*genetics
Carcinoma, Hepatocellular/pathology ; Computational Biology ; Gene Expression Profiling/methods ; Gene Expression Regulation, Neoplastic ; Gene Regulatory Networks/genetics ; Humans ; Liver Neoplasms/pathology ; RNA, Messenger/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma.
Autorzy:
Xu W; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Cancer Invasion and Metastasis Research, National Clinical Research Center for Digestive Diseases, Beijing, P.R. China.
Rao Q; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Cancer Invasion and Metastasis Research, National Clinical Research Center for Digestive Diseases, Beijing, P.R. China.
An Y; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Cancer Invasion and Metastasis Research, National Clinical Research Center for Digestive Diseases, Beijing, P.R. China.
Li M; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Cancer Invasion and Metastasis Research, National Clinical Research Center for Digestive Diseases, Beijing, P.R. China.
Zhang Z; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory of Cancer Invasion and Metastasis Research, National Clinical Research Center for Digestive Diseases, Beijing, P.R. China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Aug 23; Vol. 13 (8), pp. e0202763. Date of Electronic Publication: 2018 Aug 23 (Print Publication: 2018).
Typ publikacji:
Journal Article
MeSH Terms:
Gene Regulatory Networks*
Biomarkers, Tumor/*genetics
Carcinoma, Hepatocellular/*pathology
Gene Expression Profiling/*methods
Liver Neoplasms/*pathology
Algorithms ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/mortality ; Databases, Genetic ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/mortality ; Neoplasm Staging ; Prognosis ; Protein Interaction Maps ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway.
Autorzy:
Chen X; Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, No. 350, Shushan Hu Road, Hefei, 230031, Anhui, China.; Hefei Cancer Hospital, Chinese Academy of Sciences, No. 350, Shushan Hu Road, Hefei, 230031, Anhui, China.
Zhang S; Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, No. 350, Shushan Hu Road, Hefei, 230031, Anhui, China.; Hefei Cancer Hospital, Chinese Academy of Sciences, No. 350, Shushan Hu Road, Hefei, 230031, Anhui, China.
Wang Z; Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, No. 350, Shushan Hu Road, Hefei, 230031, Anhui, China.; University of Science and Technology of China, No. 96, Jin Zhai Road, Hefei, 230026, Anhui, China.
Wang F; School of Life Science, Anhui Medical University, No. 81, Mei Shan Road, Hefei, 230032, Anhui, China.
Cao X; School of Life Science, Anhui Medical University, No. 81, Mei Shan Road, Hefei, 230032, Anhui, China.
Wu Q; Central Laboratory of Medical Research Center, Anhui Provincial Hospital, No. 17, Lu Jiang Road, Hefei, 230001, Anhui, China.
Zhao C; Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, No. 350, Shushan Hu Road, Hefei, 230031, Anhui, China.; University of Science and Technology of China, No. 96, Jin Zhai Road, Hefei, 230026, Anhui, China.
Ma H; University of Science and Technology of China, No. 96, Jin Zhai Road, Hefei, 230026, Anhui, China.; Department of Radiation Oncology, First Affiliated Hospital, Anhui Medical University, No. 81, Mei Shan Road, Hefei, 230032, Anhui, China.
Ye F; Hefei Cancer Hospital, Chinese Academy of Sciences, No. 350, Shushan Hu Road, Hefei, 230031, Anhui, China.
Wang H; Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, No. 350, Shushan Hu Road, Hefei, 230031, Anhui, China.; Hefei Cancer Hospital, Chinese Academy of Sciences, No. 350, Shushan Hu Road, Hefei, 230031, Anhui, China.
Fang Z; Anhui Province Key Laboratory of Medical Physics and Technology, Center of Medical Physics and Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, No. 350, Shushan Hu Road, Hefei, 230031, Anhui, China. .; Hefei Cancer Hospital, Chinese Academy of Sciences, No. 350, Shushan Hu Road, Hefei, 230031, Anhui, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2018 Jun 28; Vol. 37 (1), pp. 128. Date of Electronic Publication: 2018 Jun 28.
Typ publikacji:
Journal Article
MeSH Terms:
Epithelial-Mesenchymal Transition*/genetics
Signal Transduction*
Carcinoma, Hepatocellular/*metabolism
Hypoxia/*metabolism
Liver Neoplasms/*metabolism
Membrane Proteins/*metabolism
Microfilament Proteins/*metabolism
Adult ; Aged ; Animals ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Disease Models, Animal ; Female ; Heterografts ; Humans ; Hypoxia/genetics ; Liver Neoplasms/genetics ; Liver Neoplasms/pathology ; MAP Kinase Signaling System ; Male ; Membrane Proteins/genetics ; Mice ; Microfilament Proteins/genetics ; Middle Aged ; Models, Biological ; Neoplasm Grading ; Neoplasm Metastasis ; Neoplasm Staging ; rho-Associated Kinases/metabolism ; rhoA GTP-Binding Protein/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 31

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies